168 related articles for article (PubMed ID: 32484249)
21. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
Zeng WG; Liu MJ; Zhou ZX; Wang ZJ
Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082
[TBL] [Abstract][Full Text] [Related]
22. Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
Wasmuth HH; Faerden AE; Myklebust TÅ; Pfeffer F; Norderval S; Riis R; Olsen OC; Lambrecht JR; Kørner H; Larsen SG; ; Forsmo HM; Baekkelund O; Lavik S; Knapp JC; Sjo O; Rashid G
Br J Surg; 2020 Jan; 107(1):121-130. PubMed ID: 31802481
[TBL] [Abstract][Full Text] [Related]
23. Anastomotic leakage after surgery for rectal cancer: a risk factor for local recurrence, distant metastasis and reduced cancer-specific survival?
Jörgren F; Johansson R; Damber L; Lindmark G
Colorectal Dis; 2011 Mar; 13(3):272-83. PubMed ID: 19912285
[TBL] [Abstract][Full Text] [Related]
24. Impact of rectal washout on recurrence and survival after anterior resection for rectal cancer.
Svensson Neufert R; Jörgren F; Buchwald P
BJS Open; 2022 Nov; 6(6):. PubMed ID: 36458839
[TBL] [Abstract][Full Text] [Related]
25. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
Wibe A; Syse A; Andersen E; Tretli S; Myrvold HE; Søreide O;
Dis Colon Rectum; 2004 Jan; 47(1):48-58. PubMed ID: 14719151
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
[TBL] [Abstract][Full Text] [Related]
27. The Swedish rectal cancer registry.
Påhlman L; Bohe M; Cedermark B; Dahlberg M; Lindmark G; Sjödahl R; Ojerskog B; Damber L; Johansson R
Br J Surg; 2007 Oct; 94(10):1285-92. PubMed ID: 17661309
[TBL] [Abstract][Full Text] [Related]
28. Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.
Lakkis Z; Vernerey D; Mege D; Faucheron JL; Panis Y; Tuech JJ; Lefevre JH; Brouquet A; Dumont F; Borg C; Woronoff AS; Meurisse A; Heyd B; Rullier E;
Br J Surg; 2019 Jul; 106(8):1087-1098. PubMed ID: 31074509
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of adenocarcinoma of the rectum.
Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
[TBL] [Abstract][Full Text] [Related]
30. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
32. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
33. Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer.
Quiram BJ; Crippa J; Grass F; Lovely JK; Behm KT; Colibaseanu DT; Merchea A; Kelley SR; Harmsen WS; Larson DW
Br J Surg; 2019 Jun; 106(7):922-929. PubMed ID: 30861099
[TBL] [Abstract][Full Text] [Related]
34. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Surgery; 2000 Apr; 127(4):370-6. PubMed ID: 10776426
[TBL] [Abstract][Full Text] [Related]
35. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
van Oostendorp SE; Smits LJH; Vroom Y; Detering R; Heymans MW; Moons LMG; Tanis PJ; de Graaf EJR; Cunningham C; Denost Q; Kusters M; Tuynman JB
Br J Surg; 2020 Dec; 107(13):1719-1730. PubMed ID: 32936943
[TBL] [Abstract][Full Text] [Related]
36. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
[TBL] [Abstract][Full Text] [Related]
37. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.
Chaudhry V; Nittala M; Prasad ML
Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877
[TBL] [Abstract][Full Text] [Related]
38. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.
Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E
Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333
[TBL] [Abstract][Full Text] [Related]
39. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
40. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
